NorthWest Biotherapeutics Inc (NWBO)

[colmar]

Can this question be answered? When collaborative trials with BP are established, and BP sees fit to contribute financially (measurably), what do they typically require of the jr partner in terms of trial success, etc? Are we not yet far enough along for BMY to contribute, or do they have access to info that we don't that might convince them to fund? Is it possible that BMY is waiting on results also before determining level of $ support and signing docs? TIA